Natural Killer Cell Functional Activity Suppression By Intravenous Immunoglobulin, Intralipid and Soluble Human Leukocyte Antigen-G
Authors: Roussev, Roumen G.1; Ng, Siu Chui1; Coulam, Carolyn B.
Source: American Journal of Reproductive Immunology, Volume 57, Number 4, April 2007 , pp. 262-269(8)
Publisher: Blackwell Publishing
Key:
- Free Content
- New Content
- Subscribed Content
- Free Trial Content
Abstract:
Problem The purpose of this study was to compare the ability of intravenous immunoglobulin (IVIg), intralipid and soluble human leukocyte antigen (sHLA)-G to suppress natural killer (NK) cell cytotoxicity in an in vitro assay. Method of study Blood samples taken from 275 women experiencing reproductive failure were analyzed for NK cytotoxicity and the suppression of NK cytotoxicity by IVIg 4 and 2 mg/mL (n = 275), intralipid 18 and 9 mg/mL (n = 275) and sHLA-G 70 and 35 ng/mL (n = 50) using immunofluorescent labeled K562 cells as targets and flow cytometry. Results Natural killer cytotoxicity was suppressed in all samples. Among patients with normal NK cell activity, IVIg suppressed NK cytotoxicity by 44.9 ± 8.1%, intralipid suppressed NK killing by 45.2 ± 8.3% and sHLA-G suppressed by 49.0 ± 9.2%. When specimens with abnormal NK activity were observed for suppression of cytotoxicity, IVIg suppressed by 38.9 ± 5.4%, intralipid suppressed by 39.8 ± 6.2% and sHLA-G suppressed by 39.9 ± 5.0%. Conclusion Intravenous immunoglobulin, intralipid and sHLA-G suppressed NK cell cytotoxicity with equal efficacy in an in vitro assay.Keywords: Intralipid; intravenous immunoglobulin; natural killer cell cytotoxicity; NKa; soluble human leukocyte antigen-G
Document Type: Research article
DOI: 10.1111/j.1600-0897.2007.00473.x
Affiliations: 1: Millenova Immunology Laboratories, Chicago, IL, USA;
Key:
- Free Content
- New Content
- Subscribed Content
- Free Trial Content

Click here for Page Help